The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Lamarche Jay R since 2006.
The trader's CIK number is 1242998.
At the time of the last reporting, Lamarche Jay R was the Director of Ariad Pharmaceuticals Inc. (stock ticker symbol ARIA).
Also see all insider trading activities at Ariad Pharmaceuticals Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2012 | ARIA | 0 | $0 | 60,000 | $1,101,576 | 35,000 | $128,700 |
| 2011 | ARIA | 0 | $0 | 75,000 | $471,525 | 25,000 | $141,250 |
| 2010 | ARIA | 0 | $0 | 25,000 | $125,125 | 0 | $0 |
| 2008 | ARIA | 0 | $0 | 0 | $0 | 20,000 | $0 |
| 2006 | ARIA | 0 | $0 | 26,077 | $170,520 | 34,000 | $142,460 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2012-10-01 | ARIA | Sale | 10,000 | 24.99 | 249,930 |
| 2012-09-06 | ARIA | Option Ex | 15,000 | 2.66 | 39,900 |
| 2012-08-15 | ARIA | Sale | 20,000 | 20.00 | 400,040 |
| 2012-02-28 | ARIA | Option Ex | 20,000 | 4.44 | 88,800 |
| 2012-01-27 | ARIA | Sale | 26,900 | 15.05 | 404,979 |
| 2012-01-26 | ARIA | Sale | 3,100 | 15.04 | 46,627 |
| 2011-05-09 | ARIA | Option Ex | 25,000 | 5.65 | 141,250 |
| 2011-03-25 | ARIA | Sale | 25,000 | 7.01 | 175,275 |
| 2011-02-02 | ARIA | Sale | 25,000 | 6.48 | 161,925 |
| 2011-01-11 | ARIA | Sale | 25,000 | 5.37 | 134,325 |
| 2010-12-20 | ARIA | Sale | 25,000 | 5.00 | 125,125 |
| 2008-01-18 | ARIA | Option Ex | 10,000 | .00 | 0 |
| 2008-01-17 | ARIA | Option Ex | 10,000 | .00 | 0 |
| 2006-02-15 | ARIA | Option Ex | 34,000 | 4.19 | 142,460 |
| 2006-02-14 | ARIA | Sale | 25,300 | 6.54 | 165,462 |
| 2006-02-15 | ARIA | Sale | 777 | 6.51 | 5,058 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lamarche Jay R (Director of Ariad Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.